ABSTRACT
Introduction
The repair process of wounds can be basically divided in three phases: Inflammatory with platelet accumulation, coagulation, and leukocyte migration; Proliferative which is the reparative process with re-epithelialization, neovascularization and matrix synthesis; Remodeling phase which is the period of scar contraction and collagen production 1 .
Several factors affect healing, slowing the process, for example infections, hypoxia, diabetes, ionizing radiation, aging and malnutrition Tacrolimus belong to the group of calcineurin inhibitors.
It has the effect of inhibiting the signal transduction between T lymphocytes, suppress B cell proliferation induced by Heper T-cells and inhibit the formation of cytotoxic lymphocytes, which are mainly responsible by transplan rejection 3 . It is a potent immunosuppressive however has potential side effects such as decreased reaction to the vaccine, leukopenia, thrombocytopenia, renal dysfunction, and urethral/bladder symptoms 3 . These effects could be related to changes in the healing of the urinary tract, which leads to further assess this issue.
The healing and the effects of immunosuppressants on various organs, such as intestine, pancreas and liver has been well described by some authors in various situations. Moreira described that tacrolimus produces histological changes such as edema, inflammatory infiltration and atrophy in the pancreas, in the presence of acute pancreatitis induced in experimental models 4 . Gama Filho published on the effects of tacrolimus in liver regeneration after partial hepatectomy in rats 5 . Vizzotto Junior quantified the inflammatory response in a study on the influence of cisplatin administered preoperatively and postoperatively on the healing of colonic anastomoses in rats 6 .
However, there are few studies in the literature that specifically addressed bladder wound healing under the influence of tacrolimus.
Our goal is to perform histopathological analysis of bladder healing and biochemical analysis of rats with a single kidney subjected to ischemia and reperfusion, immunosuppressed with tacrolimus, in an attempt to fill part of the gap in the current literature.
Methods
The study was approved by the Ethics Committee on device Architect I2000, Abbott Ò ).
As regards the preparation of the bladder, cystectomy was performed with full bladder section at the level of the trigone.
Realized the posterior longitudinal opening to the dome, avoiding manipulation of the anterior scar. The material was made with the mucosa in contact with the filter paper, the scar bladder in the longitudinal direction, them the bladder was placed in plastic tape and fixation made in 10% formalin.
In an orderly manner , the material that was in 10%
formalin was subjected to washing , diaphanization and embedded in paraffin . Paraffin blocks were for microtomy, cuts 4mm thick, and prepared on slides , stained by hematoxylin-eosin technique for analysis by light microscopy. The pathologist did not know which groups were being analyzed (blind study After the assignment of a numeric index to histological findings, we conducted the sum of the indices representing acute inflammation with representatives indices of chronic inflammation in each rat, thus finding the detailed histological score. This score provides an estimate of the phase of the inflammatory process in which the scar of each animal to be. Performing the average scores of each group, we could compare the groups together.
We also performed a comparison of each histological finding individualmetne between groups.
Regarding the statistical analysis, we assessed the means, standard deviations and medians of inflammatory variables, serum levels of tacrolimus, creatinine and urea. To compare the inflammatory variables between groups we used the nonparametric chi-square test, with alpha 5% (p <0.05 significance). For comparison of tacrolimus and serum urea, was used the Student t test (these variables had a normal distribution, in the Bell curve).
For the analysis of creatinine values we used the nonparametric Mann-Whitney (SH and T1 had non-normal distribution).
Analysis of the histology of the scar bladder and biochemical parameters of rats with a solitary kidney undergoing immunosuppression with tacrolimus
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Results
Despite three deaths during surgery, the groups were homogeneous with sufficient number of animals. The operative time was similar between the groups.
The values of tacrolimus showed that administration of different doses produced serum levels differents between groups.
There was statistically significant difference (p <0.05) at doses of tacrolimus serum between groups T1 x T3 (p = 0.00008) and T2 x T3 (p = 0.00003). There were differences in the doses of tacrolimus between groups T1 x T2 (p = 0.0667), however this difference was not statistically significant ( Figure 2) .
In blood urea, only the comparison T1 x T2 showed no significant difference (p>0.05). All other groups were compared with each other and presented difference, with p<0.05 ( Figure 4 ). We also had fewer mononuclear cells and granulation tissue in tacrolimus groups compared to the SH group (p <0.05).
There was a significant increase fibrosis in groups with the use of tacrolimus in comparison with the SH group (p <0.05).
Furthermore, there was statistical difference in fibrosis compared groups T1 x T2 (p = 0.009) and T2 x T3 (p = 0.0087) ( Table 2 ).
The sum of the variables in the acute phase to the chronic phase variables, which we call Detailed Score (way used by pathologists to estimate the healing phase), showed positive and higher values of the groups with the use of tacrolimus, suggesting a tendency to chronicity. (Table 2 ).
Discussion
The In the present study, the effect of tacrolimus showed deterioration in renal function with elevated serum creatinine and urea, in mice with a single kidney subjected to ischemia and reperfusion, when compared to mice that did not use the drug. Nephrotoxicity also appears to be dose-dependent, with progressive worsening of urea parallel to increase the dose of tacrolimus in groups (Figure 4 ).
Despite the presence of important aspects similiares to a kidney transplant like renal ischemia/reperfusion and bladder healing, in this study there was no antigenicity factor (generated by a graft). The antigenicity is the main reason for the use of an immunosuppressant in renal transplantation, however, when an immunosuppressant such as tacrolimus, is used without antigenicity factor, we can assess their benefits and side effects more accurately.
Another important issue is the choice of the dose of tacrolimus for experiments. Ochiai et al. 13 studied heterotopic cardiac allografts in rats treated with FK506 (tacrolimus), reported that the minimum daily oral dose for prolonging graft survival was 1 mg/kg/day. In the present study we used the standard dose of 1mg/kg at T1 group so that the dose tested in the T3 group (dose 10 times higher) do not become very toxic and there were early loss of animals, which would make the dose-dependent study unfeasible.
There are well established methods and criteria for evaluation of wound healing such as mechanical resistance of the scar, the rate of collagen and histological study 14 . As in other studies, for example Gonçalves-Filho et al. higher in groups that used cisplatin before colonic surgery.
Also used the sum score of acute with chronic variables and classified groups according to the period of evolution of the scar.
Thus reported that groups with cisplatin had a score different from non-users. Concluded that cisplatin causes slowing of healing 6 . The detailed score used in our study, in with the bladder healing in tacrolimus groups had a tendency to chronicity, was the same score used by Vizzoto Junior et al. 6 to estimate the phase of the inflammatory process, although Vizzoto Junior et al. 6 has calculated this score for colonic healing and using a chemotherapy drug.
Fumagalli et al. 16 evaluating chemotherapeutic mitomycin on the healing of colonic rats, found persistence of histological findings of acute inflammation in animals who used the drug.
Proposed that there would be persistent proliferative phase in the scar. Similar to these findings, but using an immunosuppressant and evaluating scar bladder, we also had histological scores suggestive of persistent proliverativa phase in groups with tacrolimus.
Myers et al. 17 presented a form that currently is well known, of graduate scores in healing wounds. Likewise, he considers acute inflammation, chronic inflammation, granulation tissue and collagen as parameters, however, in their scores, he also associates other factors such as abscess, crust, fibroblasts and epithelial regeneration. Similar to Myers et al. 17 , was used, in this study, positive and negative sign to the scores of acute and chronic inflammation respectively.
In agreement with the studies of tacrolimus laboratory manufacturer 3 , we found a significant decrease in neutrophil and monomorfonuclear infiltration.
Conclusions
Ischemia for 20 minutes and reperfusion showed harmful to kidney function, causing significant impairment in urea mice compared to non-operated control. Tacrolimus also presented nephrotoxic and worsening of renal function showing dose dependent.
Tacrolimus seems to favor a delay in bladder wound healing with persistence of high rates of fibrosis even after 14 days postoperatively. Also showed significant decrease in neutrophil infiltration, vascular congestion, edema, monomorfonuclear infiltration and granulation tissue.
